Barclays Reiterates Sell Rating on Avantor, Inc. Stock
Barclays analyst Luke Sergott maintained a sell rating for Avantor, Inc., setting a price target of $8, a 20.63% downside from the current price.
Key Points
- Barclays analyst Luke Sergott reiterated a sell rating on Avantor, Inc. (AVTR) with a price target of $8 on June 24, 2026.
- Barclays's $8 price target implies 20.63% downside from Avantor, Inc.'s ($AVTR) current $10.08 share price.
- Shares of AVTR traded near $9.43 on Wednesday, with a market cap of $6.38 billion and a forward P/E ratio of 10.99.
- Insider Gregory Lucier bought 10,000 shares at $8.32 on May 8, while Barclays maintained its sell rating.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Barclays analyst Luke Sergott reiterated a sell rating on Avantor, Inc. (NYSE:AVTR) on June 24, 2026, setting a price target of $8. This comes as the stock traded near $9.43 on Wednesday.
Barclays vs. the S&P 500
Hypothetical, simulated performance of disclosed positions vs. the S&P 500. Not realized profit and not investment advice. Past performance does not indicate future results. Details.
Analysts Set New Price Targets
On June 24, 2026, Barclays maintained its sell rating for Avantor, Inc., with a price target of $8. Earlier, Wolfe Research assumed coverage with a sell rating and a $7 target on June 2, 2026. RBC Capital reinstated a hold rating with a target of $9 on May 15, 2026, while Citigroup and Evercore ISI Group maintained hold ratings with targets of $9 and $8, respectively, on April 30, 2026.
Other Institutional Activity in Avantor, Inc.
Dodge & Cox increased its holdings in Avantor by 2.2%, adding 2,583,186 shares to reach a total of 119,648,329 shares, valued at approximately $938 million. BlackRock, Inc. grew its position by 10.2%, adding 6,106,628 shares, ending with 65,703,554 shares worth about $515 million. Vanguard Portfolio Management LLC opened a new position with 31,275,847 shares valued at $245 million, and Vanguard Capital Management LLC similarly initiated a stake with 30,606,112 shares worth around $240 million. Wellington Management Group LLP increased its holdings by 3.4%, adding 787,520 shares for a total of 24,224,156 shares valued at $190 million.
Avantor, Inc. Stock Down 30.9%
Shares of Avantor, Inc. traded near $9.43 on Wednesday. The company has a market cap of approximately $6.38 billion and a forward P/E ratio of 10.99. Its beta is 0.961, indicating slightly less volatility than the market. The stock's 52-week range is between $7.27 and $15.93, with a 50-day moving average of $8.50 and a 200-day moving average of $10.52. The current ratio is 1.76, and the quick ratio is 1.01, with a debt-to-equity ratio of 68.29.
$AVTR price target
Past daily closes and this analyst's 12-month price target. Not investment advice.
Insider Buying and Selling at Avantor, Inc.
On June 21, 2026, Corey Walker, President of VWR Distribution & Services, sold 3,010 shares at an average price of $9.58. Earlier in May, Gregory Lucier purchased 10,000 shares at $8.32 on May 8. Other insiders, including Louise Makin, Michael Severino, and Simon Dingemans, each acquired 25,270 shares on May 7.
About Avantor, Inc.
Avantor, Inc., headquartered in Radnor, Pennsylvania, provides essential products and services to industries like biopharma, healthcare, and advanced technologies. The company offers a range of materials, consumables, and equipment, including lab products, analytical instruments, and filtration systems. Avantor also supports scientific research with services like DNA extraction and bioreactor servicing. Led by CEO Emmanuel Ligner, Avantor employs around 13,500 people.
Bottom Line
Barclays' continued sell rating on Avantor, Inc. reflects cautious sentiment around the stock. With shares trading near $9.43 and a market cap of $6.38 billion, investors keep a close watch on analyst ratings and insider activities. Remember, 13F filings and analyst ratings are backward-looking and may not reflect the most current market conditions.
Get Avantor, Inc. alerts
New 13F filings, insider trades, and analyst moves on $AVTR, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.